{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T17:03:23Z","timestamp":1791047003719,"version":"4.1.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.modpat.2026.101013","type":"journal-article","created":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T23:32:20Z","timestamp":1778628740000},"page":"101013","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["CTNNB1-Mutant High-Grade Endometrial Carcinoma: Clinical Outcome and Prevalence of Pilomatrix-Like and Corded Hyalinized Morphologies in an Institutional Case-Control Series"],"prefix":"10.1016","volume":"39","author":[{"given":"Benjamin L.","family":"Coiner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aarti E.","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zehra","family":"Ordulu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marisa R.","family":"Nucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1420-7291","authenticated-orcid":false,"given":"Carlos","family":"Parra-Herran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.modpat.2026.101013_bib1","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s00428-020-03007-z","article-title":"ESGO\/ESTRO\/ESP guidelines for the management of patients with endometrial carcinoma","volume":"478","author":"Concin","year":"2021","journal-title":"Virchows Arch"},{"issue":"29","key":"10.1016\/j.modpat.2026.101013_bib2","doi-asserted-by":"crossref","first-page":"3388","DOI":"10.1200\/JCO.20.00549","article-title":"Molecular classification of the PORTEC-3 trial for high-risk endometrial cancer: impact on prognosis and benefit from adjuvant therapy","volume":"38","author":"Le\u00f3n-Castillo","year":"2020","journal-title":"J Clin Oncol"},{"issue":"7447","key":"10.1016\/j.modpat.2026.101013_bib3","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nature12113","article-title":"Integrated genomic characterization of endometrial carcinoma","volume":"497","author":"Kandoth","year":"2013","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.modpat.2026.101013_bib4","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1097\/PGP.0000000000001120","volume":"44","author":"Huvila","year":"2025","journal-title":"Int J Gynecol Pathol"},{"issue":"4","key":"10.1016\/j.modpat.2026.101013_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.modpat.2022.100085","article-title":"Grade and estrogen receptor expression identify a subset of no specific molecular profile endometrial carcinomas at a very low risk of disease-specific death","volume":"36","author":"Jamieson","year":"2023","journal-title":"Mod Pathol"},{"issue":"7","key":"10.1016\/j.modpat.2026.101013_bib6","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1038\/s41416-023-02141-0","article-title":"Prognostic refinement of NSMP high-risk endometrial cancers using oestrogen receptor immunohistochemistry","volume":"128","author":"Vermij","year":"2023","journal-title":"Br J Cancer"},{"key":"10.1016\/j.modpat.2026.101013_bib7","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ygyno.2025.05.015","article-title":"Prognostic significance of estrogen receptor expression and estrogen signaling in endometrial carcinomas of no specific molecular profile: a comprehensive molecular and pathologic analysis","volume":"198","author":"Lam","year":"2025","journal-title":"Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.modpat.2026.101013_bib8","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.ygyno.2014.06.010","article-title":"\u03b2-Catenin mutations in recurrent FIGO IA grade I endometrioid endometrial cancers","volume":"134","author":"Myers","year":"2014","journal-title":"Gynecol Oncol"},{"issue":"16","key":"10.1016\/j.modpat.2026.101013_bib9","doi-asserted-by":"crossref","first-page":"4215","DOI":"10.1158\/1078-0432.CCR-15-2878","article-title":"Improved risk assessment by integrating molecular and clinicopathological factors in early-stage endometrial cancer-combined analysis of the PORTEC cohorts","volume":"22","author":"Stelloo","year":"2016","journal-title":"Clin Cancer Res"},{"issue":"7","key":"10.1016\/j.modpat.2026.101013_bib10","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1038\/modpathol.2017.15","article-title":"CTNNB1 (beta-catenin) mutation identifies low grade, early stage endometrial cancer patients at increased risk of recurrence","volume":"30","author":"Kurnit","year":"2017","journal-title":"Mod Pathol"},{"issue":"2","key":"10.1016\/j.modpat.2026.101013_bib11","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/aogs.13740","article-title":"Early-stage endometrial cancer, CTNNB1 mutations, and the relation between lymphovascular space invasion and recurrence","volume":"99","author":"Imboden","year":"2020","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"3","key":"10.1016\/j.modpat.2026.101013_bib12","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.ygyno.2019.03.100","article-title":"Molecular markers in recurrent stage I, grade 1 endometrioid endometrial cancers","volume":"153","author":"Moroney","year":"2019","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.modpat.2026.101013_bib13","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s13578-020-00486-0","article-title":"Integrating pathology, chromosomal instability and mutations for risk stratification in early-stage endometrioid endometrial carcinoma","volume":"10","author":"Li","year":"2020","journal-title":"Cell Biosci"},{"key":"10.1016\/j.modpat.2026.101013_bib14","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1136\/ijgc-2020-001241","article-title":"Clinical patterns and genomic profiling of recurrent \u201cultra-low risk\u201d endometrial cancer","volume":"30","author":"Stasenko","year":"2020","journal-title":"Int J Gynecol Cancer"},{"issue":"2","key":"10.1016\/j.modpat.2026.101013_bib15","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s00404-021-06385-0","article-title":"Prognostic significance of CTNNB1 mutation in early stage endometrial carcinoma: a systematic review and meta-analysis","volume":"306","author":"Travaglino","year":"2022","journal-title":"Arch Gynecol Obstet"},{"issue":"7","key":"10.1016\/j.modpat.2026.101013_bib16","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1136\/ijgc-2021-003340","article-title":"Adjuvant treatment in early-stage endometrial cancer: context-dependent impact of somatic CTNNB1 mutation on recurrence-free survival","volume":"32","author":"Kurnit","year":"2022","journal-title":"Int J Gynecol Cancer"},{"issue":"10","key":"10.1016\/j.modpat.2026.101013_bib17","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1038\/s41379-018-0080-0","article-title":"Nuclear \u03b2-catenin localization and mutation of the CTNNB1 gene: a context-dependent association","volume":"31","author":"Kim","year":"2018","journal-title":"Mod Pathol"},{"issue":"6","key":"10.1016\/j.modpat.2026.101013_bib18","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1007\/s00428-021-03176-5","article-title":"Clinicopathological features and prognostic significance of CTNNB1 mutation in low-grade, early-stage endometrial endometrioid carcinoma","volume":"479","author":"Ruz-Caracuel","year":"2021","journal-title":"Virchows Arch"},{"issue":"2","key":"10.1016\/j.modpat.2026.101013_bib19","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/PGP.0000000000000583","article-title":"Clinicopathologic and immunohistochemical correlates of CTNNB1 mutated endometrial endometrioid carcinoma","volume":"39","author":"Costigan","year":"2020","journal-title":"Int J Gynecol Pathol"},{"issue":"10","key":"10.1016\/j.modpat.2026.101013_bib20","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1097\/PAS.0000000000001934","article-title":"Morules but not squamous differentiation are a reliable indicator of CTNNB1 (\u03b2-catenin) mutations in endometrial carcinoma and precancers","volume":"46","author":"Niu","year":"2022","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"10.1016\/j.modpat.2026.101013_bib21","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/PGP.0000000000000671","article-title":"Corded and hyalinized endometrioid adenocarcinoma (CHEC) of the uterine corpus are characterized by CTNNB1 mutations and can show adverse clinical outcomes","volume":"40","author":"Ladwig","year":"2021","journal-title":"Int J Gynecol Pathol"},{"issue":"8","key":"10.1016\/j.modpat.2026.101013_bib22","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1097\/PAS.0000000000001737","article-title":"Corded and hyalinized and spindled endometrioid endometrial carcinoma: a clinicopathologic and molecular analysis of 9 tumors based on the TCGA classifier","volume":"45","author":"Safdar","year":"2021","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"10.1016\/j.modpat.2026.101013_bib23","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1007\/s00428-022-03472-8","article-title":"Corded and hyalinized endometrioid endometrial carcinoma with high-grade features: a clinicopathological and TCGA-based molecular analysis","volume":"482","author":"Travaglino","year":"2023","journal-title":"Virchows Arch"},{"issue":"2","key":"10.1016\/j.modpat.2026.101013_bib24","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1097\/PGP.0000000000000775","article-title":"FIGO grade 3 endometrioid adenocarcinomas with diffusely aberrant \u03b2-catenin expression: an aggressive subset resembling cutaneous pilomatrix carcinomas","volume":"41","author":"Weisman","year":"2022","journal-title":"Int J Gynecol Pathol"},{"issue":"1","key":"10.1016\/j.modpat.2026.101013_bib25","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/PGP.0000000000000955","article-title":"An expanded series of pilomatrix-like high-grade endometrioid carcinoma (PiMHEC), including both MMR deficient and MMR proficient cases","volume":"43","author":"Xu","year":"2024","journal-title":"Int J Gynecol Pathol"},{"issue":"8","key":"10.1016\/j.modpat.2026.101013_bib26","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1097\/PAS.0000000000002402","article-title":"Pilomatrix-like high-grade endometrial carcinoma: an underdiagnosed entity with aggressive clinicopathologic features","volume":"49","author":"Zhou","year":"2025","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"10.1016\/j.modpat.2026.101013_bib27","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1177\/10668969251326262","article-title":"High-grade endometrial endometrioid carcinoma: a case report of complete transdifferentiation to pilomatrix-like carcinoma","volume":"33","author":"Patrichi","year":"2025","journal-title":"Int J Surg Pathol"},{"key":"10.1016\/j.modpat.2026.101013_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.humpath.2025.105928","article-title":"High-grade endometrioid carcinomas with pilomatrix-like features lacking CTNNB1 mutations: clinicopathologic characteristics and novel molecular events","volume":"164","author":"Qin","year":"2025","journal-title":"Hum Pathol"},{"issue":"19","key":"10.1016\/j.modpat.2026.101013_bib29","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.87062","article-title":"Institutional implementation of clinical tumor profiling on an unselected cancer population","volume":"1","author":"Sholl","year":"2016","journal-title":"JCI Insight"},{"issue":"6","key":"10.1016\/j.modpat.2026.101013_bib30","doi-asserted-by":"crossref","first-page":"751","DOI":"10.5858\/arpa.2016-0527-OA","article-title":"Validation of OncoPanel: a targeted next-generation sequencing assay for the detection of somatic variants in cancer","volume":"141","author":"Garcia","year":"2017","journal-title":"Arch Pathol Lab Med"},{"issue":"5","key":"10.1016\/j.modpat.2026.101013_bib31","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"issue":"1","key":"10.1016\/j.modpat.2026.101013_bib32","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.jmoldx.2016.10.002","article-title":"Standards and guidelines for the interpretation and reporting of sequence variants in cancer: a joint consensus recommendation of the Association for Molecular Pathology, American Society of Clinical Oncology, and College of American Pathologists","volume":"19","author":"Li","year":"2017","journal-title":"J Mol Diagn"},{"issue":"2","key":"10.1016\/j.modpat.2026.101013_bib33","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/01.pas.0000149704.89463.05","article-title":"Endometrioid carcinomas of the uterine corpus with sex cord-like formations, hyalinization, and other unusual morphologic features: a report of 31 cases of a neoplasm that may be confused with carcinosarcoma and other uterine neoplasms","volume":"29","author":"Murray","year":"2005","journal-title":"Am JSurg Pathol"},{"issue":"3","key":"10.1016\/j.modpat.2026.101013_bib34","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/00125480-200205000-00001","article-title":"Endometrioid carcinoma of the uterine corpus: a review of its pathology with emphasis on recent advances and problematic aspects","volume":"9","author":"Clement","year":"2002","journal-title":"Adv Anat Pathol"},{"issue":"33","key":"10.1016\/j.modpat.2026.101013_bib35","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/PGP.0000000000001081","article-title":"High-grade endometrial carcinomas with solid basaloid morphology and geographic necrosis lacking definitive pilomatrix-like features: clinicopathologic characteristics including aggressive behavior and novel molecular events","volume":"44","author":"Carlson","year":"2025","journal-title":"Int J Gynecol Pathol"},{"issue":"2","key":"10.1016\/j.modpat.2026.101013_bib36","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/ijgo.14923","article-title":"FIGO staging of endometrial cancer: 2023","volume":"162","author":"Berek","year":"2023","journal-title":"Int J Gynaecol Obstet"},{"issue":"3","key":"10.1016\/j.modpat.2026.101013_bib37","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/path.5372","article-title":"Interpretation of somatic POLE mutations in endometrial carcinoma","volume":"250","author":"Le\u00f3n-Castillo","year":"2020","journal-title":"J Pathol"},{"key":"10.1016\/j.modpat.2026.101013_bib38","doi-asserted-by":"crossref","first-page":"5492","DOI":"10.18632\/oncotarget.23695","article-title":"Exon 3 mutations of CTNNB1 drive tumorigenesis: a review","volume":"9","author":"Gao","year":"2018","journal-title":"Oncotarget"},{"issue":"3","key":"10.1016\/j.modpat.2026.101013_bib39","doi-asserted-by":"crossref","DOI":"10.1002\/cncr.35731","article-title":"POLE mutations in endometrial carcinoma: clinical and genomic landscape from a large prospective single-center cohort","volume":"131","author":"Nero","year":"2025","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.modpat.2026.101013_bib40","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/his.13772","article-title":"Nuclear \u03b2-catenin and CDX2 expression in ovarian endometrioid carcinoma identify patients with favourable outcome","volume":"74","author":"Wang","year":"2019","journal-title":"Histopathology"},{"issue":"1","key":"10.1016\/j.modpat.2026.101013_bib41","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1097\/PAS.0000000000001553","article-title":"CTNNB1 mutations and aberrant \u03b2-catenin expression in ovarian endometrioid carcinoma: correlation with patient outcome","volume":"45","author":"Zyla","year":"2021","journal-title":"Am J Surg Pathol"}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395226000566?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395226000566?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T11:23:04Z","timestamp":1784114584000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0893395226000566"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":41,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S0893395226000566"],"URL":"https:\/\/doi.org\/10.1016\/j.modpat.2026.101013","relation":{},"ISSN":["0893-3952"],"issn-type":[{"value":"0893-3952","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CTNNB1-Mutant High-Grade Endometrial Carcinoma: Clinical Outcome and Prevalence of Pilomatrix-Like and Corded Hyalinized Morphologies in an Institutional Case-Control Series","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.modpat.2026.101013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 United States & Canadian Academy of Pathology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"101013"}}